X vs. RGC

Last updated Jun 13, 2026

X (United States Steel Corporation) and RGC (Regencell Bioscience Holdings Limited) are both stocks. X operates in Steel (Basic Materials), while RGC operates in Drug Manufacturers - Specialty & Generic (Healthcare). At a correlation of -0.02, they often move in opposite directions.

Performance

X vs. RGC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United States Steel Corporation (X) and Regencell Bioscience Holdings Limited (RGC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

X

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

RGC

• 1D: -4.37%
• 1M: -31.08%
• YTD: -10.33%
• 6M: 13.43%
• 1Y: -96.92%
• 3Y*: -8.77%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

X vs. RGC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
X United States Steel Corporation	0.00%	61.75%	-29.80%	95.71%	6.15%	2.87%
RGC Regencell Bioscience Holdings Limited	-10.33%	325.10%	-52.95%	-62.35%	-12.43%	165.42%

Correlation

The correlation between X and RGC is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.11
Correlation (3Y) Calculated over the trailing 3-year period	-0.08
Correlation (All Time) Calculated using the full available price history since Jul 16, 2021	-0.02

Fundamentals

Total Revenue (TTM) X : $15.19B RGC : $0.00
Gross Profit (TTM) X : $1.15B RGC : -$40.84K
EBITDA (TTM) X : $1.10B RGC : -$8.81M

Return for Risk

X vs. RGC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

X

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

RGC

RGC Risk / Return Rank: 19
RGC Sharpe Ratio Rank: 23
RGC Sortino Ratio Rank: 24
RGC Omega Ratio Rank: 22
RGC Calmar Ratio Rank: 2
RGC Martin Ratio Rank: 22

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

X vs. RGC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United States Steel Corporation (X) and Regencell Bioscience Holdings Limited (RGC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	X	RGC	Difference
Sharpe ratio: Return per unit of total volatility	—	-0.45	—
Sortino ratio: Return per unit of downside risk	—	-0.36	—
Omega ratio: Gain probability vs. loss probability	—	0.95	—
Calmar ratio: Return relative to maximum drawdown	—	-0.99	—
Martin ratio: Return relative to average drawdown	—	-1.01	—

Drawdowns

Drawdown Indicators

	X	RGC	Difference
Max Drawdown Largest peak-to-trough decline	—	-98.82%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-98.26%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-98.82%	—
Current Drawdown Current decline from peak	—	-97.85%	—
Average Drawdown Average peak-to-trough decline	—	-64.69%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	96.08%	—

Volatility

Volatility by Period

	X	RGC	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	19.08%	—
Volatility (6M) Calculated over the trailing 6-month period	—	109.32%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	216.12%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	283.47%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	283.47%	—

Dividends

X vs. RGC - Dividend Comparison

Neither X nor RGC has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RGC Regencell Bioscience Holdings Limited	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
X United States Steel Corporation	0.00%	0.18%	0.59%	0.41%	0.80%	0.34%	0.24%	1.75%	1.10%	0.57%	0.61%	2.51%

Financials

Frequently Asked Questions

Can I hold both X and RGC in my portfolio?

X and RGC have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.